Hepatocellular Carcinoma Risk According to Regimens for Eradication of Hepatitis C Virus; Interferon or Direct Acting Antivirals

Hepatocellular Carcinoma Risk According to Regimens for Eradication of Hepatitis C Virus; Interferon or Direct Acting Antivirals

By pegylated interferon (PegIFN)-free direct-acting antivirals (DAAs) against hepatitis C virus (HCV) infection, a sustained virological response (SVR) rate >95% can be attained with a satisfactory tolerability and shorter treatment duration. However, it remains controversial whether there is any...

Full description

Bibliographic Details
Main Authors: Hye Won Lee, Dai Hoon Han, Hye Jung Shin, Jae Seung Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
Format: Article
Language:English
Published: MDPI AG 2020-11-01
Series:Cancers
Subjects:
interferon
direct-acting antivirals
hepatocellular carcinoma
prognosis
comparison
Online Access:https://www.mdpi.com/2072-6694/12/11/3414

Internet

https://www.mdpi.com/2072-6694/12/11/3414

Similar Items